Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-12 · accession 0000097745-25-000167 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | 2025-11-12 | TMO | Britt Lisa P. | SVP, Chief HR Off | S - Sale | $588.27 | -1,058 | 13.1K | -7% | -$622.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-12 | S | D | 1,057.58 | $588.27 | 13,087.23 | D | — | — |